Penserra Capital Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
VCM
VPM
DAM
Penserra Capital Management's RMD Position: Q1 2026 in Review
Penserra Capital Management held its ResMed (RMD) position steady in Q1 2026 at 12 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1017.
Penserra Capital Management first reported a position in RMD in Q4 2018 and has held it in 22 quarters since. The position peaked at $6.7M in Q2 2020. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Penserra Capital Management held 12 shares of ResMed worth $2K as of Q1 2026.
- Penserra Capital Management left its ResMed share count unchanged in Q1 2026.
- ResMed made up ﹤0.01% of Penserra Capital Management's portfolio in Q1 2026, its #1017 holding.
- Penserra Capital Management first reported a position in ResMed in Q4 2018 and has held it in 22 quarters since.
- Penserra Capital Management's ResMed position peaked at $6.7M in Q2 2020.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Penserra Capital Management's 13F filing for Q1 2026, filed 11 May 2026.